Antiplatelet therapy and vascular-access patency.
Lok
Charmaine E
CE
D001241:Aspirin / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004176:Dipyridamole / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects; D013927:Thrombosis / Q000517:prevention & control*
D003692:Delayed-Action Preparations; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin